Showing results (51-60 of 217) with videos related to
Sort By:
Pageof 22
Gynecologic Oncology|February 6, 2007
Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trialsBradley J Monk, Chunqiao Tian, Peter G Rose, et al.Gynecologic Oncology|November 22, 2020
Impact of treatment modality on overall survival in women with advanced endometrial cancer: A National Cancer Database analysisLaura M Chambers, Xuefei Jia, Peter G Rose, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 2, 2015
The Impact of Percent Reduction in CA-125 Levels on Prediction of the Extent of Interval Cytoreduction and Outcome in Patients With Advanced-Stage Cancer of Müllerian Origin Treated With Neoadjuvant ChemotherapyHaider Mahdi, Kathryn A Maurer, Benjamin Nutter, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 11, 2017
Paclitaxel, Carboplatin, and Bevacizumab in Advanced and Recurrent Endometrial CarcinomaPeter G Rose, Shamshad Ali, Mehdi Moslemi-Kebria, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2005
Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group studyRachelle Lanciano, Alison Calkins, Brian N Bundy, et al.Gynecologic Oncology|February 24, 2007
Yolk sac tumor of the ovary associated with endometrioid carcinoma with metastasis to the vagina: a case reportWilliam C McBee, Jennifer Brainard, Joram Sawady, et al.The Journal of Clinical Endocrinology and Metabolism|July 26, 2022
Index60 Is Superior to HbA1c for Identifying Individuals at High Risk for Type 1 DiabetesLaura M Jacobsen, Brian N Bundy, Heba M Ismail, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology GroupMahesh A Varia, Frederick B Stehman, Brian N Bundy, et al.Gynecologic Oncology|January 18, 2006
Sequential prolonged oral topotecan and prolonged oral etoposide as second-line therapy in ovarian or peritoneal carcinoma: a phase I Gynecologic Oncology Group studyPeter G Rose, Maurie Markman, Jeffrey G Bell, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 14, 2009
Retrospective analysis of concomitant Cisplatin during radiation in patients aged 55 years or older for treatment of advanced cervical cancer: a gynecologic oncology group studyCharles Kunos, Chunqiao Tian, Steven Waggoner, et al.Pageof 22